All companies
Visit website
NORBERT HEALTH
OperatingNorbert Health Inc
Healthcare · Founded 2019
Groundbreaking device that measures all essential vital signs without contact
Valuation cap ⓘ
$35.0M
As of Jul 2023 · from NORBERT HEALTH Future Equity SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$296,745
Across 1 round since 2023
Latest share price
$1.00
NORBERT HEALTH Future Equity SAFE 1 offering price
Financials
FY2021–FY2023 · from SEC filings · hover any figure for its source$0
−$2.9M
2021
$0
−$3.3M
2022
$0
−$3.7M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
FY2023
Income statement
Revenue
$0
$0
$0
Cost of goods sold
$0
$0
$0
Net income
-$2,885,111
-$3,330,606
-$3,700,696
Taxes paid
$0
$3,420
$2,450
Balance sheet
Cash
$3,226,871
$1,441,184
$215,256
Accounts receivable
$392,177
$38,643
$157,574
Total assets
$4,054,990
$2,672,558
$2,121,896
Short-term debt
$248,536
$28,427
$105,922
Long-term debt
$989,165
$629,233
$222,648
Total liabilities
$1,237,701
$657,660
$328,570
Other
Headcount
—
17
17
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$35.0M
Valuation cap
NORBERT HEALTH Future Equity SAFE 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $296.7K / $1.2MInvestors 172Valuation cap $35M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 1 of 3 annual reports (FY2023–FY2025)
172 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001973034Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.